Veedol Corporation Limited (NSE:VEEDOL)
1,396.90
+3.90 (0.28%)
Nov 12, 2026, 3:29 PM IST
Veedol Corporation Revenue
Veedol Corporation had revenue of 6.53B INR in the quarter ending September 30, 2026, with 28.15% growth. This brings the company's total for the last twelve months to 24.01B, up 17.80% year-over-year. In the fiscal year ending March 31, 2026, Veedol Corporation had annual revenue of 21.69B with 9.96% growth. That makes Veedol Corporation the 15,665th largest company in the world by revenue and 828th in India.
Revenue (ttm)
24.01B
Revenue Growth
+17.80%
P/S Ratio
0.98
Revenue / Employee
47.83M
Employees
502
Market Cap
23.74B
Revenue by Geography
- India 15.29B 70.5%
- Outside India 6.39B 29.5%
Fiscal year ended Mar 31, 2026 See the full Veedol Corporation breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 21.69B | 1.96B | 9.96% |
| Mar 31, 2025 | 19.72B | 395.30M | 2.05% |
| Mar 31, 2024 | 19.33B | 788.10M | 4.25% |
| Mar 31, 2023 | 18.54B | 3.18B | 20.71% |
| Mar 31, 2022 | 15.36B | 2.77B | 22.03% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Laxmi Organic Industries | 35.05B |
| Rossari Biotech | 26.61B |
| S H Kelkar and Company | 25.31B |
| Jubilant Agri and Consumer Products | 20.52B |
| NOCIL | 14.76B |
| Shree Pushkar Chemicals & Fertilisers | 11.52B |
| Advanced Enzyme Technologies | 7.82B |
| Tatva Chintan Pharma Chem | 6.50B |